CD8A and neoplasm: Some chemotherapies (e.g., doxorubicin, mitoxantrone, oxaliplatin and cyclophosphamide) may add positive immune effects by fostering CD8+ T-cell infiltration into the tumor and promoting the release of tumor antigens through the induction of immunogenic death of tumor cells [51].